300584 海辰药业
已收盘 11-17 15:00:00
资讯
新帖
简况
海辰药业(300584)11月10日股东户数2.22万户,较上期减少2.81%
证券之星 · 17:46
海辰药业(300584)11月10日股东户数2.22万户,较上期减少2.81%
海辰药业:截至11月10日收盘,公司股东户数为22179户
证券之星 · 15:03
海辰药业:截至11月10日收盘,公司股东户数为22179户
股市必读:海辰药业(300584)股东户数2.28万户,较上期增加12.68%
证券之星 · 11-11
股市必读:海辰药业(300584)股东户数2.28万户,较上期增加12.68%
海辰药业:截至10月30日收盘,公司股东户数为22821户
证券之星 · 11-10
海辰药业:截至10月30日收盘,公司股东户数为22821户
海辰药业完成新能源材料子公司全资控股;滨海能源10亿元负极项目落地;威胜控股获国网2.41亿元订单|新能源早参
每日经济新闻 · 11-03
海辰药业完成新能源材料子公司全资控股;滨海能源10亿元负极项目落地;威胜控股获国网2.41亿元订单|新能源早参
海辰药业(300584)10月28日主力资金净卖出1701.32万元
证券之星 · 10-28
海辰药业(300584)10月28日主力资金净卖出1701.32万元
海辰药业(300584)10月20日股东户数2.03万户,较上期减少1.95%
证券之星 · 10-27
海辰药业(300584)10月20日股东户数2.03万户,较上期减少1.95%
海辰药业(300584)10月27日主力资金净卖出1873.73万元
证券之星 · 10-27
海辰药业(300584)10月27日主力资金净卖出1873.73万元
海辰药业(300584)10月26日主力资金净买入1499.20万元
证券之星 · 10-26
海辰药业(300584)10月26日主力资金净买入1499.20万元
海辰药业(300584)2026年三季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 10-24
海辰药业(300584)2026年三季报简析:营收净利润同比双双增长,应收账款上升
异动快报:海辰药业(300584)10月23日9点44分触及涨停板
证券之星 · 10-23
异动快报:海辰药业(300584)10月23日9点44分触及涨停板
海辰药业(300584)披露2026年三季度报告,10月22日股价下跌3.29%
证券之星 · 10-22
海辰药业(300584)披露2026年三季度报告,10月22日股价下跌3.29%
海辰药业(300584.SZ)发布前三季度业绩,归母净利润6225.56万元,同比增长90.51%
智通财经 · 10-22
海辰药业(300584.SZ)发布前三季度业绩,归母净利润6225.56万元,同比增长90.51%
海辰药业(300584)9月30日股东户数2.07万户,较上期增加7.14%
证券之星 · 10-22
海辰药业(300584)9月30日股东户数2.07万户,较上期增加7.14%
海辰药业(300584)10月13日主力资金净卖出907.01万元
证券之星 · 10-13
海辰药业(300584)10月13日主力资金净卖出907.01万元
海辰药业(300584)10月12日主力资金净卖出1538.24万元
证券之星 · 10-12
海辰药业(300584)10月12日主力资金净卖出1538.24万元
股市必读:海辰药业(300584)股东户数2.07万户,较上期增加7.14%
证券之星 · 10-12
股市必读:海辰药业(300584)股东户数2.07万户,较上期增加7.14%
海辰药业:截至9月30日收盘,公司股东户数为20656户
证券之星 · 10-09
海辰药业:截至9月30日收盘,公司股东户数为20656户
股市必读:海辰药业(300584)股东户数1.93万户,较上期减少5.02%
证券之星 · 10-08
股市必读:海辰药业(300584)股东户数1.93万户,较上期减少5.02%
海辰药业(300584)9月10日股东户数1.93万户,较上期减少5.02%
证券之星 · 09-30
海辰药业(300584)9月10日股东户数1.93万户,较上期减少5.02%
加载更多
公司概况
公司名称:
南京海辰药业股份有限公司
所属行业:
医药制造业
上市日期:
2017-01-12
主营业务:
南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、锂电池电解液添加剂。
发行价格:
11.11
{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":28.3,"timestamp":1794898998000,"preClose":29.19,"halted":0,"volume":2250416,"delay":0,"changeRate":-0.0305,"floatShares":82131500,"shares":120000000,"eps":0.597,"marketStatus":"已收盘","change":-0.89,"latestTime":"11-17 15:00:00","open":28.83,"high":29.39,"low":28.02,"amount":64461000,"amplitude":0.0469,"askPrice":28.32,"askSize":21,"bidPrice":28.3,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.597,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794965400000},"marketStatusCode":5,"adr":0,"adjPreClose":29.19,"symbolType":"stock","openAndCloseTimeList":[[1794879000000,1794886200000],[1794891600000,1794898800000]],"highLimit":32.11,"lowLimit":26.27,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":3.21,"roa":"--","peRate":47.403685,"roe":"5.77%","epsLYR":0.3505,"committee":0.235955,"marketValue":3396000000,"turnoverRate":0.0274,"status":1,"floatMarketCap":2324000000},"requestUrl":"/m/hq/s/300584","defaultTab":"news","newsList":[{"id":"2684260689","title":"海辰药业(300584)11月10日股东户数2.22万户,较上期减少2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2684260689","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684260689?lang=zh_cn&edition=full","pubTime":"2026-11-17 17:46","pubTimestamp":1794908792,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海辰药业披露,截至2026年11月10日公司股东户数为2.22万户,较10月30日减少642.0户,减幅为2.81%。在化学制药行业个股中,海辰药业股东户数低于行业平均水平,截至11月10日,化学制药行业平均股东户数为3.97万户。从股价来看,2026年10月30日至2026年11月10日,海辰药业区间涨幅为1.92%,在此期间股东户数减少642.0户,减幅为2.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700031632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684674934","title":"海辰药业:截至11月10日收盘,公司股东户数为22179户","url":"https://stock-news.laohu8.com/highlight/detail?id=2684674934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684674934?lang=zh_cn&edition=full","pubTime":"2026-11-17 15:03","pubTimestamp":1794898995,"startTime":"0","endTime":"0","summary":"证券之星消息,海辰药业(300584)11月17日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止2026年11月10日的股东户数是多少?谢谢海辰药业回复:尊敬的投资者您好,截至11月10日收盘,公司股东户数为22179户,感谢关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700022151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682310260","title":"股市必读:海辰药业(300584)股东户数2.28万户,较上期增加12.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682310260","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682310260?lang=zh_cn&edition=full","pubTime":"2026-11-11 02:47","pubTimestamp":1794336432,"startTime":"0","endTime":"0","summary":"截至2026年11月10日收盘,海辰药业报收于32.34元,上涨2.18%,换手率4.2%,成交量3.45万手,成交额1.11亿元。股本股东变化:截至2026年10月30日,公司股东户数为2.28万户,较10月20日增加12.68%。股本股东变化股东户数变动截至2026年10月30日公司股东户数为2.28万户,较10月20日增加2568.0户,增幅为12.68%;户均持股数量由上期的5925.0股减少至5258.0股,户均持股市值为16.68万元。谢谢董秘: 尊敬的投资者您好,截至10月30日收盘,公司股东户数为22821户,感谢关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100006122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682352866","title":"海辰药业:截至10月30日收盘,公司股东户数为22821户","url":"https://stock-news.laohu8.com/highlight/detail?id=2682352866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682352866?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281924,"startTime":"0","endTime":"0","summary":"证券之星消息,海辰药业(300584)11月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最新一期的股东户数是多少?谢谢海辰药业回复:尊敬的投资者您好,截至10月30日收盘,公司股东户数为22821户,感谢关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680279145","title":"海辰药业完成新能源材料子公司全资控股;滨海能源10亿元负极项目落地;威胜控股获国网2.41亿元订单|新能源早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2680279145","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680279145?lang=zh_cn&edition=full","pubTime":"2026-11-03 07:03","pubTimestamp":1793660581,"startTime":"0","endTime":"0","summary":"丨2026年11月3日星期二丨NO.1海辰药业完成收购新能源材料公司11月2日晚间,海辰药业公告,公司以6450.83万元收购3位股东所持有的安庆汇辰10%股权,以0元收购1位股东所持有的安庆汇辰15%股权,并承接该15%股权对应的7500万元实缴出资义务。相关工商变更登记已办理完毕。本次交易完成后,公司持有安庆汇辰100%股权,后者成为公司全资子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033919222936.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033919222936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000941.SH","BK0177","IE00B031HY20.USD","BK1179","LU0320764599.SGD","LU1808992512.USD","LU0164939612.USD","03393","IE0008368742.USD","SGXZ62798434.SGD","300584","SGXZ86797644.SGD","LU0082770016.USD","BK0102","IE0008369823.USD","160640","399941","LU0082770016.SGD","BK0263","000695","159875","LU0052750758.USD","BK0081","BK0239","LU0620787316.HKD","BK0013","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678455429","title":"海辰药业(300584)10月28日主力资金净卖出1701.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678455429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678455429?lang=zh_cn&edition=full","pubTime":"2026-10-28 15:34","pubTimestamp":1793172848,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月28日收盘,海辰药业报收于33.47元,下跌1.99%,换手率11.39%,成交量9.35万手,成交额3.11亿元。10月28日的资金流向数据方面,主力资金净流出1701.32万元,占总成交额5.47%,游资资金净流出785.09万元,占总成交额2.52%,散户资金净流入2486.41万元,占总成交额7.99%。海辰药业主营业务:化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800029908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175206","title":"海辰药业(300584)10月20日股东户数2.03万户,较上期减少1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175206?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:52","pubTimestamp":1793098367,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海辰药业披露,截至2026年10月20日公司股东户数为2.03万户,较9月30日减少403.0户,减幅为1.95%。在化学制药行业个股中,海辰药业股东户数低于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.84万户。从股价来看,2026年9月30日至2026年10月20日,海辰药业区间跌幅为9.65%,在此期间股东户数减少403.0户,减幅为1.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678125308","title":"海辰药业(300584)10月27日主力资金净卖出1873.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678125308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678125308?lang=zh_cn&edition=full","pubTime":"2026-10-27 15:30","pubTimestamp":1793086210,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,海辰药业报收于34.15元,上涨1.31%,换手率15.55%,成交量12.77万手,成交额4.43亿元。10月27日的资金流向数据方面,主力资金净流出1873.73万元,占总成交额4.23%,游资资金净流出325.62万元,占总成交额0.73%,散户资金净流入2199.35万元,占总成交额4.96%。海辰药业主营业务:化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700024035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678415793","title":"海辰药业(300584)10月26日主力资金净买入1499.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678415793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678415793?lang=zh_cn&edition=full","pubTime":"2026-10-26 15:29","pubTimestamp":1792999755,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月26日收盘,海辰药业报收于33.71元,上涨5.08%,换手率19.32%,成交量15.87万手,成交额5.28亿元。10月26日的资金流向数据方面,主力资金净流入1499.2万元,占总成交额2.84%,游资资金净流入887.98万元,占总成交额1.68%,散户资金净流出2387.19万元,占总成交额4.52%。海辰药业主营业务:化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600014853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677970079","title":"海辰药业(300584)2026年三季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2677970079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677970079?lang=zh_cn&edition=full","pubTime":"2026-10-24 06:09","pubTimestamp":1792793384,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期海辰药业发布2026年三季报。截至本报告期末,公司营业总收入6.15亿元,同比上升30.49%,归母净利润6225.56万元,同比上升90.51%。按单季度数据看,第三季度营业总收入2.51亿元,同比上升54.11%,第三季度归母净利润3019.06万元,同比上升757.5%。本报告期海辰药业应收账款上升,应收账款同比增幅达76.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400005363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677791666","title":"异动快报:海辰药业(300584)10月23日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2677791666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677791666?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:45","pubTimestamp":1792719949,"startTime":"0","endTime":"0","summary":"证券之星10月23日盘中消息,9点44分海辰药业(300584)触及涨停板。其所属行业化学制药目前下跌。领涨股为海辰药业。该股为化学原料药,肝炎概念,医药概念热股。10月22日的资金流向数据方面,主力资金净流出94.02万元,占总成交额1.73%,游资资金净流出165.19万元,占总成交额3.03%,散户资金净流入259.21万元,占总成交额4.76%。近5日资金流向一览见下表:海辰药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300011477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677964631","title":"海辰药业(300584)披露2026年三季度报告,10月22日股价下跌3.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677964631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677964631?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:44","pubTimestamp":1792680258,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,海辰药业报收于26.73元,较前一交易日下跌3.29%,最新总市值为32.08亿元。近日,海辰药业披露《2026年三季度报告》。报告显示,2026年第三季度营业收入251,134,364.41元,比上年同期增长54.11%;归属于上市公司股东的净利润30,190,575.39元,同比增长757.50%。年初至报告期末营业收入615,282,448.06元,同比增长30.49%;归属于上市公司股东的净利润62,255,558.94元,同比增长90.51%;扣除非经常性损益后的净利润66,697,481.27元,同比增长125.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200043028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677296598","title":"海辰药业(300584.SZ)发布前三季度业绩,归母净利润6225.56万元,同比增长90.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677296598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677296598?lang=zh_cn&edition=full","pubTime":"2026-10-22 20:58","pubTimestamp":1792673931,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海辰药业(300584.SZ)发布2026年第三季度报告,公司前三季度实现营业收入6.15亿元,同比增长30.49%;归属于上市公司股东的净利润6225.56万元,同比增长90.51%;归属于上市公司股东的扣除非经常性损益的净利润6669.75万元,同比增长125.76%;基本每股收益0.5188元。前三季度,公司营收增长主要原因为报告期子公司安庆汇辰锂电材料业务量产后增加营业收入增加所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677956992","title":"海辰药业(300584)9月30日股东户数2.07万户,较上期增加7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677956992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677956992?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:53","pubTimestamp":1792662833,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海辰药业披露,截至2026年9月30日公司股东户数为2.07万户,较9月10日增加1377.0户,增幅为7.14%。在化学制药行业个股中,海辰药业股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.68万户。从股价来看,2026年9月10日至2026年9月30日,海辰药业区间涨幅为4.56%,在此期间股东户数增加1377.0户,增幅为7.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200030871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392983","title":"海辰药业(300584)10月13日主力资金净卖出907.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392983?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:34","pubTimestamp":1791876890,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,海辰药业报收于30.8元,下跌2.69%,换手率7.3%,成交量6.0万手,成交额1.81亿元。10月13日的资金流向数据方面,主力资金净流出907.01万元,占总成交额5.02%,游资资金净流出1113.11万元,占总成交额6.16%,散户资金净流入2020.12万元,占总成交额11.17%。海辰药业主营业务:化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300020597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674054822","title":"海辰药业(300584)10月12日主力资金净卖出1538.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674054822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674054822?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:33","pubTimestamp":1791790429,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月12日收盘,海辰药业报收于31.65元,下跌5.58%,换手率7.64%,成交量6.28万手,成交额2.03亿元。10月12日的资金流向数据方面,主力资金净流出1538.24万元,占总成交额7.58%,游资资金净流出78.3万元,占总成交额0.39%,散户资金净流入1616.54万元,占总成交额7.97%。海辰药业主营业务:化学制剂、原料药及中间体的研发、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674457348","title":"股市必读:海辰药业(300584)股东户数2.07万户,较上期增加7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674457348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674457348?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:41","pubTimestamp":1791744069,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,海辰药业报收于33.52元,下跌0.83%,换手率11.25%,成交量9.24万手,成交额3.07亿元。股本股东变化:截至2026年9月30日股东户数为2.07万户,较9月10日增加7.14%。股本股东变化股东户数变动截至2026年9月30日公司股东户数为2.07万户,较9月10日增加1377.0户,增幅为7.14%;户均持股数量由6224.0股减少至5809.0股,户均持股市值为18.11万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674830880","title":"海辰药业:截至9月30日收盘,公司股东户数为20656户","url":"https://stock-news.laohu8.com/highlight/detail?id=2674830880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674830880?lang=zh_cn&edition=full","pubTime":"2026-10-09 11:36","pubTimestamp":1791517000,"startTime":"0","endTime":"0","summary":"证券之星消息,海辰药业(300584)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至9月30日公司股东人数是多少,谢谢海辰药业回复:尊敬的投资者您好,截至9月30日收盘,公司股东户数为20656户,感谢关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900015144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673179720","title":"股市必读:海辰药业(300584)股东户数1.93万户,较上期减少5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673179720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673179720?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:10","pubTimestamp":1791400224,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,海辰药业报收于31.18元,上涨1.56%,换手率4.83%,成交量3.97万手,成交额1.24亿元。当日关注点交易信息汇总:9月30日主力资金净流出143.19万元,占总成交额1.15%。股本股东变化:截至9月10日股东户数为1.93万户,较8月31日减少5.02%,户均持股数量增至6224.0股。谢谢董秘: 尊敬的投资者您好,截至9月10日收盘,公司股东户数为19279户,感谢关注!公司三季报将于10月23日披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671007277","title":"海辰药业(300584)9月10日股东户数1.93万户,较上期减少5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671007277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671007277?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:28","pubTimestamp":1790760517,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海辰药业披露,截至2026年9月10日公司股东户数为1.93万户,较8月31日减少1018.0户,减幅为5.02%。在化学制药行业个股中,海辰药业股东户数低于行业平均水平,截至9月10日,化学制药行业平均股东户数为3.64万户。从股价来看,2026年8月31日至2026年9月10日,海辰药业区间跌幅为4.12%,在此期间股东户数减少1018.0户,减幅为5.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000027508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794921119391,"stockEarnings":[{"period":"1week","weight":-0.0777},{"period":"1month","weight":0.0523},{"period":"3month","weight":-0.1561},{"period":"6month","weight":-0.2311},{"period":"1year","weight":-0.593},{"period":"ytd","weight":-0.4173}],"compareEarnings":[{"period":"1week","weight":-0.0159},{"period":"1month","weight":-0.0306},{"period":"3month","weight":-0.0972},{"period":"6month","weight":-0.1345},{"period":"1year","weight":-0.0972},{"period":"ytd","weight":-0.0923}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22179人(较上一季度减少2.81%)","perCapita":"3703股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":" 南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、锂电池电解液添加剂。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}